HHLR ADVISORS, LTD. - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 139 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
HHLR ADVISORS, LTD. ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$12,137,131
+23.4%
698,7410.0%0.27%
+29.0%
Q2 2023$9,838,273
-10.2%
698,741
-31.4%
0.21%
+8.2%
Q1 2023$10,954,659
-72.1%
1,018,091
-61.2%
0.19%
-76.6%
Q4 2022$39,306,382
+4.8%
2,623,924
-10.1%
0.83%
-15.8%
Q3 2022$37,493,000
+32.5%
2,920,0230.0%0.99%
+62.4%
Q2 2022$28,295,000
-2.5%
2,920,0230.0%0.61%
+0.2%
Q1 2022$29,025,000
-15.5%
2,920,0230.0%0.61%
+14.1%
Q4 2021$34,369,000
+3.3%
2,920,0230.0%0.53%
+22.1%
Q3 2021$33,259,000
-18.2%
2,920,0230.0%0.44%
+3.8%
Q2 2021$40,676,000
-24.7%
2,920,0230.0%0.42%
-21.5%
Q1 2021$54,050,000
+4.8%
2,920,0230.0%0.53%
+30.2%
Q4 2020$51,597,000
+15.3%
2,920,0230.0%0.41%
+20.9%
Q3 2020$44,735,000
-28.2%
2,920,023
+19.5%
0.34%
-40.4%
Q2 2020$62,269,000
+112.2%
2,443,833
+28.9%
0.57%
+43.7%
Q1 2020$29,348,000
+40.0%
1,895,8880.0%0.40%
+51.7%
Q4 2019$20,969,000
+31.9%
1,895,888
+1.5%
0.26%
+19.7%
Q3 2019$15,893,000
-36.1%
1,867,622
+1.7%
0.22%
-60.8%
Q2 2019$24,858,000
-25.0%
1,835,8880.0%0.56%
-39.8%
Q1 2019$33,156,000
-15.0%
1,835,888
+32.2%
0.92%
-42.9%
Q4 2018$39,014,0001,388,8881.62%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 2,474,561$42,983,1255.17%
Rubric Capital Management LP 3,077,449$53,455,2892.00%
Parkman Healthcare Partners LLC 509,810$8,855,4001.62%
TANG CAPITAL MANAGEMENT LLC 600,000$10,422,0001.47%
AlphaCentric Advisors LLC 110,000$1,910,7001.08%
Lion Point Capital, LP 130,691$2,270,1031.01%
RICE HALL JAMES & ASSOCIATES, LLC 650,366$11,296,8570.72%
ESSEX INVESTMENT MANAGEMENT CO LLC 185,853$3,228,2670.53%
ADVISORY RESEARCH INC 204,098$3,545,1820.49%
Jackson Creek Investment Advisors LLC 65,607$1,1400.48%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders